Claims for Patent: 11,053,280

✉ Email this page to a colleague

Summary for Patent: 11,053,280

Title:	Anti-VEGF protein compositions and methods for producing the same
Abstract:	The present disclosure pertains to compositions comprising aflibercept and methods for producing such compositions in chemically defined media and using chromatography to reduce amounts of certain aflibercept variants.
Inventor(s):	Tustian Andrew, Vartak Ankit, Daly Thomas, Pyles Erica, Palackal Nisha, Wang Shunhai, Li Ning
Assignee:	Regeneron Pharmaceuticals, Inc.
Application Number:	US16996007
Patent Claims:

Details for Patent 11,053,280

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Regeneron Pharmaceuticals, Inc.	EYLEA	aflibercept	Injection	125387	November 18, 2011	⤷ Get Started Free	2040-08-18
Regeneron Pharmaceuticals, Inc.	EYLEA	aflibercept	Injection	125387	August 16, 2018	⤷ Get Started Free	2040-08-18
Regeneron Pharmaceuticals, Inc.	EYLEA HD	aflibercept	Injection	761355	August 18, 2023	⤷ Get Started Free	2040-08-18
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,053,280

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
South Africa	202208710	⤷ Get Started Free
South Africa	202107647	⤷ Get Started Free
South Africa	202107646	⤷ Get Started Free
South Africa	202107644	⤷ Get Started Free
World Intellectual Property Organization (WIPO)	2021113591	⤷ Get Started Free
World Intellectual Property Organization (WIPO)	2021112929	⤷ Get Started Free
World Intellectual Property Organization (WIPO)	2021112928	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.